Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAMI-BAS: Early vs Late Beta Blockers, ACEI, and SGLT2i in STEMI
NCT06562582Phase 4Recruiting
- Sponsor
- Region Västra Götaland
- Start
- Jan 2025
- Primary completion
- Dec 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bisoprolol, ramipril and dapagliflozin in myocardial infarction (MI) (6 arms), sponsored by Region Västra Götaland. Primary endpoint: Global Longitudinal Strain at day 7. Started Jan 2025; status: recruiting.
02
Drugs
bisoprololramiprildapagliflozin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT06562582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06562582.